Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Increases By 15.9%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 16,000 shares, an increase of 15.9% from the October 31st total of 13,800 shares. Based on an average daily volume of 255,500 shares, the days-to-cover ratio is presently 0.1 days.

Biodexa Pharmaceuticals Stock Up 0.3 %

NASDAQ BDRX traded up $0.02 during trading on Tuesday, hitting $5.87. The company’s stock had a trading volume of 22,513 shares, compared to its average volume of 150,077. Biodexa Pharmaceuticals has a 52 week low of $3.50 and a 52 week high of $103.00. The business’s 50 day moving average is $5.44.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.